Dr. Haendel's vision is to fundamentally alter the fabric of biomedical science, utilizing her art as a data translator to weave together healthcare systems, basic science research, and patients; through development of data integration technologies, innovative communication strategies, and collaborative...
News
Premal Patel is a physician-scientist with 15 years of experience in medical oncology drug development, thoughtfully combining clinical strategy with adept biomarker approaches. Most recently, Premal was the SVP, Head of Early Clinical Drug Development at Juno therapeutics where he...
Kathryn P. Pennington, MD, is a faculty member in gynecologic oncology. She specializes in the treatment of gynecologic cancers, including ovarian, uterine, cervical, vulvar and vaginal cancers, as well as gestational trophoblastic disease. Dr. Pennington's clinical expertise includes minimally-invasive surgery...
Dr. Rio's work is focused on gene therapy and gene editing strategies to correct hematopoietic stem cells in patients with Fanconi anemia. Her team has designed a therapeutic lentiviral vector carrying the FANCA gene that has received orphan drug designation...
Using Fanconi anemia and other genetic disease as a backdrop, Dr. Smogorzewska’s research aims to elucidate pathways that prevent stem cell dysfunction, and cancer development, with a focus on those that repair DNA. Throughout its lifetime, a cell’s DNA is...
Dr. Wagner's research has focused on the development of new treatment approaches for life-threatening diseases for which conventional treatments are unsatisfactory. Dr. Wagner is recognized for pioneering the use of double umbilical cord blood transplantation in adults and embryo selection...